Target Price | $10.29 |
Price | $5.33 |
Potential |
93.16%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Aldeyra Therapeutics, Inc. 2026 .
The average Aldeyra Therapeutics, Inc. target price is $10.29.
This is
93.16%
register free of charge
$12.00
125.35%
register free of charge
$8.00
50.23%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend Aldeyra Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aldeyra Therapeutics, Inc. stock has an average upside potential 2026 of
93.16%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.94 | -0.11 |
46.88% | 88.30% | |
P/E | negative | |
EV/Sales | 2.80 |
7 Analysts have issued a Aldeyra Therapeutics, Inc. forecast for earnings per share. The average Aldeyra Therapeutics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Aldeyra Therapeutics, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.